Relative positivity has continued into a second straight day this week as the market leans perhaps more into encouraging signs around the future of interest rates than the prospect of renewed conflict in the Middle East.
Those jitters nonetheless appear to have propelled de-SPACs in the oil and gas sector to a good day despite the fact that oil prices themselves remain largely unchanged.
Oil & gas has generally been fruitful for SPACs in general with 19 such deals completed since December 2012. Of this group, three either last closed or were earlier acquired for more than $20 per share and four more continue to trade in the teens.
Sitio Royalites (NYSE:STR), which combined with Osprey Energy in 2018 is up +1.2% on the day to about $23.86 while TPG Pace Energy‘s target Magnolia Oil & Gas (NYSE:MGY) was similarly up about +1% to $22.71 as of this writing.
Satellite companies that got to market via SPAC deals have seen even bigger bumps today. With much of their revenue coming from the defense sector and conflict-researchers, the market appears to see them as having new work in the pipeline.
BlackSky (NYSE:BKSY) is on a +18% run two years out from completing its combination with Osprey Technology, while Israeli satellite operator Satixfy (NYSE:SATX) is recovering +27.7% after taking a hit yesterday in the market’s initial reaction to the new Gaza violence
Peer space de-SPACs Terran Orbital (NYSE:LLAP), Rocket Lab (NASDAQ:RKLB) are each up about +5%, while AST SpaceMobile (NASDAQ:ASTS) has seen a +7.7% boost in the early afternoon and Planet Labs (NYSE:PL) is up +1.7%.
The outlier in the group that has not been taken on a similar ride is Satellogic (NASDAQ:SATL) which is down -2.7% so far today.
Overall, these companies, given their early and in some cases pre-profitability nature, have not been graced with the same enthusiasm as oil and gas de-SPACs overall, however, and they all collectively last closed at a median share price of $0.78, adjusted for stock splits.
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...
NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...